Scientists have revealed that simple tests on human saliva would be capable of diagnosing diabetes and cancer at an early stage and perhaps other neurological disorders and autoimmune diseases.
The study has brought to light that saliva contained many of the same disease-revealing molecules that were contained in blood.
Dr. David Wong, a senior author of the research and UCLA's Felix and Mildred Yip Endowed Professor in Dentistry has said that if they could analyze constituents in saliva that could mark someone who has pre-diabetes or the early stages of oral cancer or pancreatic cancer and they could utilize this knowledge for personalized medicine.
The UCLA scientists have identified more than 400 circular RNAs in human saliva that was the first discovery of circular RNA in saliva or any body fluid that included 327 forms that were previously unknown.
While most RNA molecules translate genetic code from DNA to make proteins, there were also classes called non-coding RNAs that do not.
Saliva has been carrying with it non-coding RNAs, microRNAs, piRNAs and circRNAs that were biomarkers for disease and health monitoring without this study scientists would have never known that non-coding RNAs, microRNAs, piRNAs and circRNAs existed in saliva.
Their overriding conclusion was that saliva has tremendous medical and scientific value. In the not-too-distant future, dentists would be able to take saliva samples to analyze for a variety of diseases.
Wong had said that the research could lead to a new category of self-diagnostic devices.
The study was published online by the peer-reviewed journal Clinical Chemistry.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
